Literature DB >> 7690296

Tenascin is increased in cartilage and synovium from arthritic knees.

D M Salter1.   

Abstract

Tenascin is a major extracellular glycoprotein known to have important functions in processes such as wound repair and embryogenesis including bone and cartilage formation. The expression of this molecule in articular cartilage and synovium from normal and abnormal (OA and inflammatory joint disease including RA) human knee joints was studied by an immunohistological technique using paraffin embedded tissue and a specific anti-human tenascin monoclonal antibody (BC4). The results show that in normal articular cartilage tenascin is expressed in small amounts in the surface zone and in synovium is present in significant levels in the walls of blood vessels only. In diseased joints expression is greatly increased both in articular cartilage and synovium. Increased production of tenascin is likely to be part of a reparative response in injured joints the understanding of which may suggest novel mechanisms to modify disease progression in degenerative and inflammatory joint disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690296     DOI: 10.1093/rheumatology/32.9.780

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  17 in total

1.  Expression of tenascin in joint-associated tissues during development and postnatal growth.

Authors:  E J Mackie; S Ramsey
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

2.  Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

Authors:  Kim Midwood; Sandra Sacre; Anna M Piccinini; Julia Inglis; Annette Trebaul; Emma Chan; Stefan Drexler; Nidhi Sofat; Masahide Kashiwagi; Gertraud Orend; Fionula Brennan; Brian Foxwell
Journal:  Nat Med       Date:  2009-06-28       Impact factor: 53.440

3.  Expression of tenascin-C in aseptic loosening of total hip replacement.

Authors:  Y T Konttinen; T F Li; O Michelsson; J W Xu; T Sorsa; S Santavirta; S Imai; I Virtanen
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

4.  Tenascin-C and human tendon degeneration.

Authors:  G P Riley; R L Harrall; T E Cawston; B L Hazleman; E J Mackie
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

Review 5.  Therapeutics for tendon regeneration: a multidisciplinary review of tendon research for improved healing.

Authors:  J J Paredes; Nelly Andarawis-Puri
Journal:  Ann N Y Acad Sci       Date:  2016-10-21       Impact factor: 5.691

6.  The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation.

Authors:  S Schenk; R Chiquet-Ehrismann; E J Battegay
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

7.  Tenascin-C Prevents Articular Cartilage Degeneration in Murine Osteoarthritis Models.

Authors:  Yuriyo Matsui; Masahiro Hasegawa; Takahiro Iino; Kyoko Imanaka-Yoshida; Toshimichi Yoshida; Akihiro Sudo
Journal:  Cartilage       Date:  2016-12-04       Impact factor: 4.634

Review 8.  Problems and paradigms in joint pathology.

Authors:  D L Gardner
Journal:  J Anat       Date:  1994-06       Impact factor: 2.610

9.  Tenascin and aggrecan expression by articular chondrocytes is influenced by interleukin 1beta: a possible explanation for the changes in matrix synthesis during osteoarthritis.

Authors:  D Pfander; N Heinz; P Rothe; H-D Carl; B Swoboda
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

10.  A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA).

Authors:  W A Wallace; E A Ramage; D Lamb; S E Howie
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.